Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemophilia
•
Primary Care
Do you incorporate DVT prophylaxis after joint arthroscopy in a patient with hemophilia?
If so, what is your preferred agent?
Related Questions
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
How would you manage aplastic anemia refractory to multiple agents?
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?